Results of the summarizing process for the arXiv paper: 2401.16355v1

In the realm of Artificial Intelligence, the advent of large multimodal models has revolutionized the potential for advancements in pathology. However, a significant hindrance to their development and accurate evaluation has been the absence of specialized, high-quality benchmarks. To tackle this challenge head-on, a groundbreaking initiative known as PathMMU has been introduced. stands as the largest and most meticulously vetted pathology benchmark tailored specifically for . This comprehensive benchmark comprises an impressive array of 33,573 multimodal multi-choice questions accompanied by 21,599 images sourced from various channels. Notably, each question is complemented by a detailed explanation elucidating the correct answer. The creation of leverages the robust capabilities of GPT-4V, harnessing approximately 30,000 curated image-caption pairs to generate an extensive set of Questions and Answers (Q&As). To ensure the utmost credibility and reliability of , a panel of six esteemed pathologists rigorously scrutinize each question within both its validation and test sets. Simultaneously, these experts establish an expert-level performance benchmark against which can be measured. A series of exhaustive evaluations have been conducted to gauge the efficacy and resilience of 14 open-sourced and three closed-sourced LMMs when faced with the formidable challenges posed by . Additionally, representative LMMs have undergone fine-tuning processes to assess their adaptability to this rigorous benchmark. The empirical findings reveal that even advanced LMMs struggle when confronted with the complexities inherent in the benchmark. The top-performing LLM, GPT-4V, achieves a modest zero-shot performance rate of only 51.7%, significantly lower than the impressive 71.4% demonstrated by human pathologists. Following fine-tuning efforts, certain open-sourced LMMs manage to surpass GPT-4V with performance rates exceeding 60%. However, they still fall short when compared to the expertise exhibited by human pathologists. It is hoped that through its establishment and meticulous curation process, will not only provide invaluable insights but also catalyze advancements in developing more specialized next-generation Large Multimodal Models tailored specifically for applications in pathology.

• - The introduction of large multimodal models has revolutionized advancements in pathology.
• - Lack of specialized, high-quality benchmarks has hindered the development and evaluation of these models.
• - PathMMU is a groundbreaking initiative that serves as the largest and most meticulously vetted pathology benchmark.
• - PathMMU comprises 33,573 multimodal multi-choice questions and 21,599 images with detailed explanations for each question.
• - It leverages GPT-4V to generate an extensive set of Questions and Answers (Q&As).
• - A panel of six esteemed pathologists rigorously scrutinizes each question within PathMMU's validation and test sets to establish an expert-level performance benchmark.
• - Empirical evaluations show that even advanced LMMs struggle with the challenges posed by PathMMU.
• - The top-performing LLM, GPT-4V, achieves a modest zero-shot performance rate of 51.7%, lower than human pathologists' 71.4%.
• - Certain open-sourced LMMs surpass GPT-4V after fine-tuning but still fall short compared to human pathologists' expertise.
• - PathMMU aims to provide invaluable insights and catalyze advancements in developing more specialized next-generation Large Multimodal Models for pathology applications.

SummaryLarge multimodal models have changed how we study diseases. But without good tests, it's hard to make them better. PathMMU is a big test for these models with lots of questions and images. It uses GPT-4V to create questions and answers. Expert pathologists check the test questions carefully. Even the best model, GPT-4V, can't beat human pathologists yet. Definitions- Multimodal: Using different types of information or data. - Benchmarks: Standards or tests used to measure performance. - Pathology: The study of diseases. - Initiative: A new plan or project. - Empirical: Based on observation or experience. - Expertise: Specialized knowledge or skill in a particular field.

In the world of Artificial Intelligence (AI), one of the most exciting developments has been the emergence of large multimodal models. These models have opened up a whole new realm of possibilities for advancements in pathology, but their progress has been hindered by a lack of specialized and high-quality benchmarks. To address this challenge, an innovative initiative known as PathMMU has been introduced. PathMMU stands as the largest and most meticulously vetted pathology benchmark tailored specifically for AI applications. This comprehensive benchmark comprises an impressive array of 33,573 multimodal multi-choice questions accompanied by 21,599 images sourced from various channels. What sets PathMMU apart is that each question is complemented by a detailed explanation elucidating the correct answer. The creation of PathMMU leverages the robust capabilities of GPT-4V, harnessing approximately 30,000 curated image-caption pairs to generate an extensive set of Questions and Answers (Q&As). This ensures that not only are there a vast number of questions available for evaluation but also that they are diverse and cover a wide range of topics within pathology. To ensure utmost credibility and reliability, PathMMU undergoes rigorous scrutiny from a panel consisting of six esteemed pathologists. They carefully review each question within both its validation and test sets to ensure accuracy and relevance. Additionally, these experts establish an expert-level performance benchmark against which all models can be measured. A series of exhaustive evaluations have been conducted to gauge the efficacy and resilience of 14 open-sourced and three closed-sourced Large Multimodal Models (LMMs) when faced with the formidable challenges posed by PathMMU. The results reveal that even advanced LLMs struggle when confronted with the complexities inherent in this benchmark. The top-performing LLM on zero-shot learning is GPT-4V with a modest performance rate of only 51.7%. This falls significantly short compared to human pathologists, who demonstrate an impressive 71.4% performance rate. However, through fine-tuning processes, certain open-sourced LMMs manage to surpass GPT-4V with performance rates exceeding 60%. While this is a significant improvement, it still falls short when compared to the expertise exhibited by human pathologists. The findings from PathMMU's evaluations not only provide invaluable insights into the capabilities of current LMMs but also highlight the need for more specialized models tailored specifically for applications in pathology. By establishing and meticulously curating this benchmark, PathMMU aims to catalyze advancements in developing next-generation Large Multimodal Models that can excel in the field of pathology. In conclusion, PathMMU stands as a groundbreaking initiative that addresses a crucial gap in AI research – the lack of high-quality benchmarks for pathology applications. Its comprehensive and rigorous approach ensures credibility and reliability while providing valuable insights into the capabilities of current LLMs. With its establishment, it is hoped that PathMMU will not only aid in advancing AI technology but also contribute towards improving healthcare outcomes through accurate and efficient diagnosis.